Long-term therapy of heart failure with prazosin: a randomized double blind trial.

[1]  L. Benet,et al.  Attenuation of prazosin effect on cardiac output in chronic heart failure. , 1979, Annals of internal medicine.

[2]  E. Sonnenblick,et al.  Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure. , 1979, The American journal of cardiology.

[3]  J A Parker,et al.  Regional Ejection Fraction A Quantitative Radionuclide Index of Regional Left Ventricular Performance , 1979, Circulation.

[4]  B. Brundage,et al.  Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure. , 1979, The American journal of cardiology.

[5]  G. Nicolosi,et al.  Alpha-adrenergic blocking activity of prazosin. Effect on catecholamine levels and catecholamine synthetic enzymes. , 1979, Biochemical pharmacology.

[6]  R. Gorlin,et al.  Hemodynamic and Clinical Tachyphylaxisc to Prazosin-Mediated Afterload Reductionin Severe Chronic Congestive Heart Failure , 1979, Circulation.

[7]  W. Pettinger,et al.  Drug therapy. Prazosin. , 1979, The New England journal of medicine.

[8]  W. Aronow,et al.  Effect of Prazosin vs Placebo on Chronic Left Ventricular Heart Failure , 1979, Circulation.

[9]  M. Packer,et al.  Oral vasodilator therapy for chronic heart failure: a plea for caution. , 1978, The American journal of cardiology.

[10]  W R Brody,et al.  Ejection fraction by count rate from gated images. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  S. Snyder,et al.  Prazosin: differential affinities for two populations of α-noradrenergic receptor binding sites , 1978 .

[12]  J A Parker,et al.  Ejection fraction image: a noninvasive index of regional left ventricular wall motion. , 1978, The American journal of cardiology.

[13]  C. Conti,et al.  Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure. , 1978, The American journal of cardiology.

[14]  R. Miller,et al.  Comparison of Effects of Nitroprusside and Prazosin on Left Ventricular Function and the Peripheral Circulation in Chronic Refractory Congestive Heart Failure , 1978, Circulation.

[15]  R. Miller,et al.  Efficacy of Ambulatory Systemic Vasodilator Therapy with Oral Prazosin in Chronic Refractory Heart Failure: Concomitant Relief of Pulmonary Congestion and Elevation of Pump Output Demonstrated by Improvements in Symptomatology, Exercise Tolerance, Hemodynamics and Echocardiography , 1977, Circulation.

[16]  E. Braunwald.  Vasodilator therapy--a physiologic approach to the treatment of heart failure. , 1977, The New England journal of medicine.

[17]  R. Miller,et al.  Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin. , 1977, The New England journal of medicine.

[18]  J. Cohn,et al.  Vasodilator therapy of cardiac failure (second of two parts). , 1977, The New England journal of medicine.

[19]  J. Mahony,et al.  LONG‐TERM USE OF PRAZOSIN IN COMBINATION OR ALONE FOR TREATING HYPERTENSION , 1977, The Medical journal of Australia.

[20]  J A Parker,et al.  Radionuclide left ventriculography with the slant hole collimator. , 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  J. Cohn,et al.  Vasodilator Therapy of Cardiac Failure , 1977 .

[22]  W. Parmley,et al.  Combination vasodilator therapy for severe chronic congestive heart failure. , 1976, Annals of internal medicine.

[23]  R. Miller,et al.  Pharmacological Mechanisms for Left Ventricular Unloading in Clinical Congestive Heart Failure: Differential Effects of Nitropmsside, Phentolamine, and Nitroglycerin on Cardiac Function and Peripheral Circulation , 1976, Circulation research.

[24]  K. Shine,et al.  Vasodilator Therapy for Chronic Left Ventricular Failure , 1976, Circulation.

[25]  R Gorlin,et al.  Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. , 1976, The American journal of cardiology.

[26]  J. Cohn,et al.  Hemodynamic Effects of Orally Administered Isosorbide Dinitrate in Patients with Congestive Heart Failure , 1974, Circulation.

[27]  J. Cohn,et al.  Treatment of refractory heart failure with infusion of nitroprusside. , 1974, The New England journal of medicine.

[28]  W. Mroczek,et al.  Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo. , 1974, Current therapeutic research, clinical and experimental.

[29]  S. Z. Langer,et al.  Presynaptic regulation of catecholamine release. , 1974, Biochemical pharmacology.

[30]  J. Koch-weser.  Vasodilation for Vasospastic Hypertension , 1973 .

[31]  W. Campbell,et al.  Adrenergic Component of Renin Release Induced by Vasodilating Antihypertensive Drugs in the Rat , 1973, Circulation research.

[32]  G. Williams,et al.  Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma. , 1973, The Journal of laboratory and clinical medicine.

[33]  W. Henry,et al.  Asymmetric Septal Hypertrophy: Echocardiographic Identification of the Pathognomonic Anatomic Abnormality of IHSS , 1973, Circulation.

[34]  E. Braunwald,et al.  Alterations in regional hemodynamics in experimental heart failure in conscious dogs. , 1972, Transactions of the Association of American Physicians.

[35]  R. Bruce,et al.  Exercise stress testing in evaluation of patients with ischemic heart disease. , 1969, Progress in cardiovascular diseases.